![Frontiers | Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus Frontiers | Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus](https://www.frontiersin.org/files/Articles/675670/fendo-12-675670-HTML/image_m/fendo-12-675670-g001.jpg)
Frontiers | Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus
![Frontiers | Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus Frontiers | Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus](https://www.frontiersin.org/files/Articles/675670/fendo-12-675670-HTML/image_m/fendo-12-675670-t001.jpg)
Frontiers | Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus
![Dioxin Cancer Risk — Example of Hormesis? - Jouko Tuomisto, Juha Pekkanen, Hannu Kiviranta, Erkki Tukiainen, Terttu Vartiainen, Matti Viluksela, Jouni T. Tuomisto, 2005 Dioxin Cancer Risk — Example of Hormesis? - Jouko Tuomisto, Juha Pekkanen, Hannu Kiviranta, Erkki Tukiainen, Terttu Vartiainen, Matti Viluksela, Jouni T. Tuomisto, 2005](https://journals.sagepub.com/cms/10.2203/dose-response.003.03.004/asset/images/large/10.2203_dose-response.003.03.004-fig4.jpeg)